Back to Massachusetts

H1379 • 2025

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

Active

The official status still shows this bill as active or still awaiting another formal step.

Sponsor
Michael P. Kushmerek
Last action
2026-04-16
Official status
Referred to House Committee on Ways and Means
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program By Representative Kushmerek of Fitchburg, a petition (accompanied by bill, House, No.

What This Bill Does

  • An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program By Representative Kushmerek of Fitchburg, a petition (accompanied by bill, House, No.
  • 1379) of Michael P.
  • Kushmerek relative to exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program.
  • Health Care Financing.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-04-16 House

    Bill reported favorably by committee and referred to the committee on House Ways and Means

  2. 2026-03-19 House

    Reporting date extended to Monday, June 15, 2026

  3. 2025-09-15 House

    Reporting date extended to Wednesday, March 18, 2026

  4. 2025-06-24 Joint

    Hearing scheduled for 07/01/2025 from 10:00 AM-12:30 PM in Gardner Auditorium

  5. 2025-02-27 House

    Referred to the committee on Health Care Financing

  6. 2025-02-27 Senate

    Senate concurred

Official Summary Text

An Act exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program
By Representative Kushmerek of Fitchburg, a petition (accompanied by bill, House, No. 1379) of Michael P. Kushmerek relative to exempting medications used for the treatment of opioid use disorder from the prior approval process under the Massachusetts Medicaid program. Health Care Financing.
Status:
Referred to House Committee on Ways and Means

Current Bill Text

Read the full stored bill text
×

Bill H.1379

Section 51A of Chapter 118E of the Massachusetts General Laws, is hereby amended in paragraph (a) by striking the definition of “Step Therapy Protocol” and inserting in place thereof the following new definition: --

“Step Therapy Protocol”, a utilization management policy or program that establishes the specific sequence in which a prescription drug for a specified medical condition is covered by the division or an entity with which the division contracts to provide or manage health insurance benefits; provided, however, the provisions of such utilization management policy or program and any regulations requiring prior authorization for prescription drugs shall not apply to any medications prescribed by a health care provider for the treatment of opioid use disorder.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Close